[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367902-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367902-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","panoramic-analysis-of-the-biological-function-and-clinical-value-of-slc38a2-in-human-cancers-a-study-based-on-pan-cancer-and-single-cell-analysis","Panoramic analysis of the biological function and clinical value of SLC38A2 in human cancers - a study based on pan-cancer and single-cell analysis","","Glutamine metabolic reprogramming drives tumor progression and is linked to poor outcomes, while the amino acid transporter SLC38A2 remains insufficiently characterized for its biological roles and prognostic significance. Using bioinformatics, researchers integrate TCGA, GTEx, Human Protein Atlas, and GEO data to evaluate expression, mutations, and prognostic models across cancers, and perform single-cell analyses across 12 cancer types. Findings identify SLC38A2 as a diagnostic and risk-related biomarker and connect it to glutathione metabolism and immune-related patterns in tumor microenvironments.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/panoramic-analysis-of-the-biological-function-and-clinical-value-of-slc38a2-in-human-cancers-a-study-based-on-pan-cancer-and-single-cell-analysis/367902/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/panoramic-analysis-of-the-biological-function-and-clinical-value-of-slc38a2-in-human-cancers-a-study-based-on-pan-cancer-and-single-cell-analysis/367902.png","ImageObject",300,407,{"name":42,"@type":43},"Bulrr","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal regarding SLC38A2 in cancer?","Question",{"text":63,"@type":64},"To perform a comprehensive bioinformatics analysis of SLC38A2 across multiple cancers, clarifying its biological function and prognostic value in tumor progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data resources and analytic approaches are used?",{"text":68,"@type":64},"Gene expression and clinical data are integrated from TCGA, GTEx, Human Protein Atlas, and GEO, followed by expression/mutation assessment, prognostic model construction, and single-cell enrichment analyses in 12 cancer types.",{"name":70,"@type":61,"acceptedAnswer":71},"How does SLC38A2 relate to prognosis and immune involvement?",{"text":72,"@type":64},"SLC38A2 shows differential expression across cancers, acts as a prognostic risk factor in several specified cancers, correlates positively with tumor/stromal cells, and is associated with immune exhaustion with negative correlation to immune cell infiltration.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367902,1790239603,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","TYPE Original Research PUBLISHED 17 September 2025 DOI 10.3389/fgene.2025.1658299  \nOPEN ACCESS  \nEDITED BY  \nDomenico Mallardo,  \nG. Pascale National Cancer Institute Foundation (IRCCS), Italy  \nREVIEWED BY  \nFatemeh Maghool,  \nIsfahan University of Medical Sciences, Iran Pei Shengbin,  \nChinese Academy of Medical Sciences and Peking Union Medical College, China  \n*CORRESPONDENCE  \nYanzong Zhao,  \n [zhaoyz21@lzu.edu.cn](zhaoyz21@lzu.edu.cn)[ ](zhaoyz21@lzu.edu.cn)Sheng Li,  \n [doctorlisheng@163.com](doctorlisheng@163.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 03 July 2025  \nACCEPTED 27 August 2025  \nPUBLISHED 17 September 2025  \nCITATION  \nLiao M, Rao Y, Li M, Guo J, Guo K, Li K, Zheng R, Liu Y, Wang Q, Wang M, Chen D, Zhang M, Wang Y, Zhao Y and Li S (2025) Panoramic analysis of the biological function and clinical value of SLC38A2 in human cancers: a study based on pan-cancer and single-cell analysis. Front. Genet. 16:1658299 .  \ndoi: 10.3389/fgene.2025.1658299  \nCOPYRIGHT  \n© 2025 Liao, Rao, Li, Guo, Guo, Li, Zheng, Liu, Wang, Wang, Chen, Zhang, Wang, Zhao and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPanoramic analysis of the biological function and clinical value of SLC38A2 in human cancers: a study based on pan-cancer and single-cell analysis  \nMao Liao 1†, Yuqing Rao 2†, Molan Li 3†, Jiayang Guo 4, Kun Guo 1, Kaiyue Li 4, Rui Zheng 4, Yifan Liu 4, Qianyi Wang 4, Manni Wang 4, Duo Chen 5, Meng Zhang 4, Yongfeng Wang 6, Yanzong Zhao 􀀁 4* and Sheng Li 􀀁 6*  \n1The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China, 2College of International Education, Henan University of Technology, Zhengzhou, China, 3The First Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China, 4School of Stomatology, Lanzhou University, Lanzhou, China, 5School of Life Science, Lanzhou University, Lanzhou, China, 6The First People ’s Hospital of Lanzhou City, Lanzhou, China  \nBackground: Glutamine metabolic reprogramming is a hallmark of tumor progression and is highly correlated with poor clinical outcomes. The excessive uptake of glutamine by tumor cells is a key factor contributing to widespread invasion, metastasis, and immune suppression. SLC38A2, an amino acid transporter widely expressed on the surface of tumor cells, has not been thoroughly studied regarding its function and prognostic signiﬁcance in tumor progression. Our objective is to employ bioinformatics methods to conduct a comprehensive and in-depth analysis of SLC38A2 across various cancers, aiming to elucidate its role and prognostic value in tumor biology.  \nMethods: By comprehensively incorporating gene expression and clinical data from the TCGA tumor database, GTEx database, Human Protein Atlas, and GEO database, we analyzed the expression proﬁle, mutations, and established prognostic models for SLC38A2 across various cancers. Additionally, we investigated the enrichment of SLC38A2 at the single-cell level in 12 types of cancer and analyzed its temporal expression patterns in different cell subgroupsin breast and pancreatic cancer. We also studied the correlation between SLC38A2 and glutathione metabolism.  \nResults: Compared to normal tissues, SLC38A2 exhibits signiﬁcant differential expression in 15 types of cancer and serves as a prognostic risk factor in BRCA (HR = 1 . 597, p \u003C 0. 05), LUAD (HR = 1 . 650, p \u003C 0. 01), MESO (HR = 2 . 007, p \u003C 0. 05), and PAAD (HR = 1 .761, p \u003C 0. 05), while acting as a protective factor in KIRC (HR = 0. 625, p \u003C 0. 05) . Furthermore, SLC38A2 is","cbCaipaPil7HLk9Y","https://ap.wps.com/l/cbCaipaPil7HLk9Y","pdf",9605921,17,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the study’s main goal regarding SLC38A2 in cancer?\",\"answer\":\"To perform a comprehensive bioinformatics analysis of SLC38A2 across multiple cancers, clarifying its biological function and prognostic value in tumor progression.\"},{\"question\":\"Which data resources and analytic approaches are used?\",\"answer\":\"Gene expression and clinical data are integrated from TCGA, GTEx, Human Protein Atlas, and GEO, followed by expression/mutation assessment, prognostic model construction, and single-cell enrichment analyses in 12 cancer types.\"},{\"question\":\"How does SLC38A2 relate to prognosis and immune involvement?\",\"answer\":\"SLC38A2 shows differential expression across cancers, acts as a prognostic risk factor in several specified cancers, correlates positively with tumor/stromal cells, and is associated with immune exhaustion with negative correlation to immune cell infiltration.\"}]","Panoramic analysis of the biological function and clinical value of SLC38A2 in human cancers - a study based on pan-cancer and single-cell analysis | PDF",1790173229,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/220bbaa815fef4a1f015cf29140be094.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9737a9c07a877e8c5d9ad47fd0ce44e4.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd805cf50bd8415609dfa630250fe51e.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9dbca9af488ddedcc70f1206a4900c6e.webp",980,1385]